Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/10/2019
SIETES contiene 92822 citas

 
 
<< anterior 21 a 40 de 513 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [Ref.ID 100612]
22.Tiene citas relacionadas Cita con resumen
Jureidini J. Antidepressants fail, but no cause for therapeutic gloom. Lancet 2016;388:844-5. [Ref.ID 100611]
23. Cita con resumen
Anónimo. Citalopram, escitalopram et allongements de l'intervalle QT. Prescrire 2016;36:348-51. [Ref.ID 100539]
24.Enlace a cita original Cita con resumen
Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol 2016;81:589-604. [Ref.ID 100178]
25. Cita con resumen
Dyer C. GSK is fined £38m for delaying generic paroxetine. BMJ 2016;352:i917. [Ref.ID 100059]
26.Tiene citas relacionadas Cita con resumen
Gotzsche PC. Antidepressants are addictive and increase the risk of relapse. BMJ 2016;352:i574. [Ref.ID 100055]
27.Tiene citas relacionadas Cita con resumen
Dubicka B, Cole-King A, Reynolds S, Ramchandani P. Paper on suicidality and aggression during antidepressant treatment was flawed and the press release was misleading. BMJ 2016;352:i911. [Ref.ID 100053]
28. Cita con resumen
Dyer C. Judge might reopen GSK paroxetine case. BMJ 2016;352:i800. [Ref.ID 100045]
30. Cita con resumen
Anónimo. UK fines GlaxoSmithKline $54 million for pay-to-delay deals. DIA Daily 2016:1. [Ref.ID 99999]
32. Cita con resumen
Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015;351:h4320. [Ref.ID 99581]
34. Cita con resumen
Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA, on behalf of the National Birth Defects Prevention Study. Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports. BMJ 2015;351:h3190. [Ref.ID 99250]
35.Tiene citas relacionadas Cita con resumen
Shin J-Y, Park M-J, Lee SH, Choi S-H, Kim M-H, Choi N-K, Lee J, Park B-J. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ 2015;351:h3517. [Ref.ID 99249]
36. Cita con resumen
Gotzsche PC, Young AH, Crace J. Does long term use of psychiatric drugs cause more harm than good?. BMJ 2015;350:h2435. [Ref.ID 99101]
37. Cita con resumen
Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mills E. Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis. J Am Geriatr Soc 2015;63:1002-9. [Ref.ID 99078]
38.Tiene citas relacionadas Cita con resumen
Coupland C, Hill TMorriss R, Arthur A, Moore M, Hippisley-Cox J. Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database. BMJ 2015;350:h517. [Ref.ID 98877]
39.Tiene citas relacionadas
Campbell NL, Boustani MA. Adverse cognitive effects of medications: turning attention to reversibility. JAMA Intern Med 2015;175:408-9. [Ref.ID 98843]
40.Tiene citas relacionadas Cita con resumen
Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Krane PK, Larson EB. Cumulative use of strong anticholinergics and incident dementia. A prospective cohort study. JAMA Intern Med 2015;175:401-7. [Ref.ID 98842]
Seleccionar todas
 
<< anterior 21 a 40 de 513 siguiente >>